A team of researchers at University of Texas found that this is the first to assess the long-term effect of eye drops that lower the eyeball (intraocular) pressure on those at risk of glaucoma.

Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of ...

Medically reviewed by Christine L. Larsen, MD Medically reviewed by Christine L. Larsen, MD Glaucoma is a group of eye diseases that can lead to vision loss and blindness. It is caused by damage to ...

He added that because the procedure is still relatively new, it is currently only ... have been trying to move away from using eye drops to treat glaucoma because of their adverse effects.

Glaucoma is the leading cause of blindness worldwide. Its symptoms do not present themselves in an obvious way, which has led to the condition being dubbed the ‘silent thief of sight’.

For the second year in a row, Bausch + Lomb has joined with the Glaucoma Research Foundation to launch the “Faces of Glaucoma ...

“New treatments for the dry form of macular ... eye during cataract surgery and help decrease the need for eye drops to treat glaucoma. There are also more injectable medications emerging ...

Glaucoma is a disease of the optic nerve of the eye, which is a major cause of irreversible blindness in the world ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national nonprofit ...

Background Normal tension glaucoma ... right eye was used for statistical analysis. Results In 41 right eyes, the mean pre-study IOP was 14.3 ± 3.4 mmHg while on 1.5 ± 0.8 eye drops.

New Jersey is at a critical crossroads in ... provided better long-term treatment for glaucoma than eye drops. More than 3 million Americans have glaucoma, a number that is expected to double ...